After customer backlash, Oxford Nanopore extended support for its PromethION 2 Solo (P2 Solo) sequencer through the end of 2030. The company will stop selling the P2 Solo later this year but will continue hardware, software, and kit support longer than initially announced to allow labs time to transition. The decision follows widespread user criticism about losing affordable, accessible sequencing options used in decentralized and academic workflows. Continued P2 Solo support preserves sequencing capacity for teams that depend on the platform for local, lower‑cost long‑read applications while Oxford encourages migration to integrated platforms.